<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is the third most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in the world </plain></SENT>
<SENT sid="1" pm="."><plain>The risk of <z:hpo ids='HP_0011420'>death</z:hpo> is closely correlated to the stage of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> at the time of primary diagnosis </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, there is a compelling need for the identification of blood biomarkers that can enable early detection of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We used a quantitative proteomic approach with isobaric labeling (iTRAQ) to examine changes in the plasma proteome of 10 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> compared to healthy volunteers </plain></SENT>
<SENT sid="4" pm="."><plain>Enzyme-Linked Immunosorbnent Assay (ELISA) and Western blot were used for further validation </plain></SENT>
<SENT sid="5" pm="."><plain>In our quantitative proteomics analysis, we detected 75 human plasma proteins with more than 95% confidence using iTRAQ labeling in conjunction with microQ-TOF MS </plain></SENT>
<SENT sid="6" pm="."><plain>9 up-regulated and 4 down-regulated proteins were observed in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> group </plain></SENT>
<SENT sid="7" pm="."><plain>The ORM2 level in plasma was confirmed to be significantly elevated in patients suffering from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> compared with the controls </plain></SENT>
<SENT sid="8" pm="."><plain>ORM2 expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues was significantly increased compared with that in corresponding adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> mucous tissues (P&lt;0.001) </plain></SENT>
<SENT sid="9" pm="."><plain>ITRAQ together with Q-TOF/MS is a sensitive and reproducible technique of quantitative proteomics </plain></SENT>
<SENT sid="10" pm="."><plain>Alteration in expression of ORM2 suggests that ORM2 could be used as a potential biomarker in the diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>